|
1.
|
Lustig B and Behrens J: The Wnt signaling
pathway and its role in tumor development. J Cancer Res Clin Oncol.
129:199–221. 2003.PubMed/NCBI
|
|
2.
|
Prunier C, Hocevar BA and Howe PH: Wnt
signaling: physiology and pathology. Growth Factors. 22:141–150.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Kimelman D and Xu W: beta-catenin
destruction complex: insights and questions from a structural
perspective. Oncogene. 25:7482–7491. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
MacDonald BT, Tamai K and He X:
Wnt/beta-catenin signaling: components, mechanisms, and diseases.
Dev Cell. 17:9–26. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Jiang Y, Luo W and Howe PH: Dab2
stabilizes Axin and attenuates Wnt/beta-catenin signaling by
preventing protein phosphatase 1 (PP1)-Axin interactions. Oncogene.
28:2999–3007. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
He X, Semenov M, Tamai K and Zeng X: LDL
receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling:
arrows point the way. Development. 131:1663–1677. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Zeng X, Tamai K, Doble B, et al: A
dual-kinase mechanism for Wnt co-receptor phosphorylation and
activation. Nature. 438:873–877. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Gertler FB, Bennett RL, Clark MJ and
Hoffmann FM: Drosophila abl tyrosine kinase in embryonic CNS
axons: a role in axonogenesis is revealed through dosage-sensitive
interactions with disabled. Cell. 58:103–113. 1989. View Article : Google Scholar
|
|
9.
|
Kim JA, Bae SH, Choi YJ, Kim KH and Park
SS: Feed-back regulation of disabled-2 (Dab2) p96 isoform for
GATA-4 during differentiation of F9 cells. Biochem Biophys Res
Commun. 421:591–598. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Fu L, Rab A, Tang LP, Rowe SM, Bebok Z and
Collawn JF: Dab2 is a key regulator of endocytosis and
post-endocytic trafficking of the cystic fibrosis transmembrane
conductance regulator. Biochem J. 441:633–643. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Hung WS, Huang CL, Fan JT, Huang DY, Yeh
CF, Cheng JC and Tseng CP: The endocytic adaptor protein Disabled-2
is required for cellular uptake of fibrinogen. Biochim Biophys
Acta. 1823:1778–1788. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Hocevar BA, Smine A, Xu XX and Howe PH:
The adaptor molecule Disabled-2 links the transforming growth
factor beta receptors to the Smad pathway. EMBO J. 20:2789–2801.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Jiang Y, Prunier C and Howe PH: The
inhibitory effects of Disabled-2 (Dab2) on Wnt signaling are
mediated through Axin. Oncogene. 27:1865–1875. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Jiang Y, He X and Howe PH: Disabled-2
(Dab2) inhibits Wnt/beta-catenin signalling by binding LRP6 and
promoting its internalization through clathrin. EMBO J.
31:2336–2349. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Karam JA, Shariat SF, Huang HY, et al:
Decreased DOC-2/DAB2 expression in urothelial carcinoma of the
bladder. Clin Cancer Res. 13:4400–4406. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Yang DH, Smith ER, Cohen C, et al:
Molecular events associated with dysplastic morphologic
transformation and initiation of ovarian tumorigenicity. Cancer.
94:2380–2392. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Kleeff J, Huang Y, Mok SC, Zimmermann A,
Friess H and Büchler MW: Down-regulation of DOC-2 in colorectal
cancer points to its role as a tumor suppressor in this malignancy.
Dis Colon Rectum. 45:1242–1248. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Anupam K, Tusharkant C, Gupta SD and Ranju
R: Loss of disabled-2 expression is an early event in esophageal
squamous tumorigenesis. World J Gastroenterol. 12:6041–6045.
2006.PubMed/NCBI
|
|
19.
|
Chetrit D, Barzilay L, Horn G, Bielik T,
Smorodinsky NI and Ehrlich M: Negative regulation of the endocytic
adaptor disabled-2 (Dab2) in mitosis. J Biol Chem. 286:5392–5403.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Yang DH, Smith ER, Roland IH, et al:
Disabled-2 is essential for endodermal cell positioning and
structure formation during mouse embryogenesis. Dev Biol.
251:27–44. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Zhu W, Zheng J and Fang W: Isolation and
characterization of human lung cancer cell subline with different
metastatic potential. Zhonghua Bing Li Xue Za Zhi. 24:136–138.
1995.(In Chinese).
|
|
22.
|
Liu CR, Ma CS, Ning JY, You JF, Liao SL
and Zheng J: Differential thymosin beta 10 expression levels and
actin filament organization in tumor cell lines with different
metastatic potential. Chin Med J (Engl). 117:213–218.
2004.PubMed/NCBI
|
|
23.
|
Xu HT, Wei Q, Liu Y, et al: Overexpression
of axin down-regulates TCF-4 and inhibits the development of lung
cancer. Ann Surg Oncol. 14:3251–3259. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Cheung KK, Mok SC, Rezaie P and Chan WY:
Dynamic expression of Dab2 in the mouse embryonic central nervous
system. BMC Dev Biol. 8:762008. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Martin JC, Herbert BS and Hocevar BA:
Disabled-2 down-regulation promotes epithelial-to-mesenchymal
transition. Br J Cancer. 103:1716–1723. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Bagadi SA, Prasad CP, Srivastava A,
Prashad R, Gupta SD and Ralhan R: Frequent loss of Dab2 protein and
infrequent promoter hypermethylation in breast cancer. Breast
Cancer Res Treat. 104:277–286. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Xu HT, Yang LH, Li QC, Liu SL, Liu D, Xie
XM and Wang EH: Disabled-2 and Axin are concurrently colocalized
and underexpressed in lung cancers. Hum Pathol. 42:1491–1498. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Tong JH, Ng DC, Chau SL, et al: Putative
tumour-suppressor gene DAB2 is frequently down regulated by
promoter hyper-methylation in nasopharyngeal carcinoma. BMC Cancer.
10:2532010. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Hannigan A, Smith P, Kalna G, et al:
Epigenetic downregulation of human disabled homolog 2 switches
TGF-beta from a tumor suppressor to a tumor promoter. J Clin
Invest. 120:2842–2857. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Yang Y, Zhang Q, Xu F, Chang C and Li X:
Aberrant promoter methylation of Dab2 gene in myelodysplastic
syndrome. Eur J Haematol. 89:469–477. 2012. View Article : Google Scholar : PubMed/NCBI
|
